Quibim
PrivateLast Round
Series A
Jan 28, 2025
Total Funding Raised
$61.71M
Company Overview
Quibim is a health technology company that develops artificial intelligence (AI) powered solutions for medical imaging analysis. The company's platform processes data from MRI, CT, and PET scans to extract quantitative imaging biomarkers, which are used for diagnostics, outcome prediction, and to accelerate drug development. Its main products include QP-Prostate, QP-Brain, and QP-Liver, which are used by healthcare providers and pharmaceutical companies. Quibim's mission is to transform imaging into a key tool for precision health, with a long-term vision of creating 'human digital twins' to better monitor health and test treatments virtually. The company has a global presence with headquarters in Spain and offices in the US and UK.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quibim Comps
Public and private peers based on sector, stage, and business model.
Quibim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2025 | ||||
| Seed | Jul 21, 2020 | ||||
| Grant | Dec 1, 2018 | ||||
| Grant | Feb 1, 2018 |
Quibim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Amadeus Capital Partners | Series A, Seed |
| Partech | Seed, Series A |
| Partech | Series A |
| Leadwind | Series A |
| GED Capital | Series A |
| Build Collective | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2025
Launched AI-QUAL for automated prostate MRI image quality assessment.
- Jan 28, 2025
$50M Series A round completed.
Quibim Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quibim's valuation, stock price, and market status.
